139 related articles for article (PubMed ID: 5049924)
1. Combination phase 1-II study of imidazole carboxamide (NCS45388).
Wagner DE; Ramirez G; Weiss AJ; Hill G
Oncology; 1972; 26(2):310-6. PubMed ID: 5049924
[No Abstract] [Full Text] [Related]
2. Mitomycin (Mutamycin).
Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
[No Abstract] [Full Text] [Related]
3. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
Kingra GS; Comis R; Olson KB; Horton J
Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
[No Abstract] [Full Text] [Related]
4. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
Skibba JL; Ramirez G; Beal DD; Bryan GT
Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
[No Abstract] [Full Text] [Related]
5. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
[No Abstract] [Full Text] [Related]
6. Chemotherapy in prevention of the recurrence of resectable cancer.
Bonadonna G; Tancini G; Rossi A; Gasparini M
Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
[No Abstract] [Full Text] [Related]
7. The systemic chemotherapy of hepatic metastases.
Kemeny N
Semin Oncol; 1983 Jun; 10(2):148-58. PubMed ID: 6346494
[No Abstract] [Full Text] [Related]
8. Clinical cancer chemotherapy aimed at potential cell regulators.
Knock FE; Galt RM; Renaud OV; Oester YT
Arch Surg; 1970 Feb; 100(2):167-72. PubMed ID: 5460788
[No Abstract] [Full Text] [Related]
9. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
Luce JK; Thurman WG; Isaacs BL; Talley RW
Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
[No Abstract] [Full Text] [Related]
10. [SM-108].
Uzuka Y; Saito Y
Gan No Rinsho; 1985 May; 31(6 Suppl):757-66. PubMed ID: 4032756
[TBL] [Abstract][Full Text] [Related]
11. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
Sullivan RD; Miller E
Cancer Res; 1965 Aug; 25(7):1025-33. PubMed ID: 4284747
[No Abstract] [Full Text] [Related]
12. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for common solid tumors.
Berstock DA; Baum M
Adv Cancer Res; 1983; 39():315-27. PubMed ID: 6353886
[No Abstract] [Full Text] [Related]
14. Clinical experience with mitomycin C (NSC-26980).
Whittington RM; Close HP
Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
[No Abstract] [Full Text] [Related]
15. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Panettiere F; Coltman CA
Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
[No Abstract] [Full Text] [Related]
16. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
Gerner RE; Moore GE
Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
[No Abstract] [Full Text] [Related]
17. [Polychemotherapy of malignant tumors and hemoblastoses].
Kühböck J; Pokorny D; Steinbach K; Eggerth G
Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
[No Abstract] [Full Text] [Related]
18. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
Slack NM; Jones R
Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
[No Abstract] [Full Text] [Related]
19. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Cersosimo RJ; Hong WK
J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
[TBL] [Abstract][Full Text] [Related]
20. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
Fink DJ; Foye LV
Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
[No Abstract] [Full Text] [Related]
[Next] [New Search]